Press Releases - Geneoscopy -Transforming Gastrointestinal Health

Geneoscopy’s Preventive Screening Test for Colorectal Cancer and Precancerous Adenomas Earns FDA Breakthrough Device Designation. January 13, 2020. by Geneoscopy. …

CouponFollow Extension

$6
OFF

Geneoscopy Raises $6.9 Million To Advance Preventive Screening …

6 days from now

Oct 2, 2019 · The Company plans to use the proceeds from this financing to advance its colorectal cancer (CRC) screening test, which quantifies eukaryotic RNA isolated from …

businesswire.com

$6
OFF

Geneoscopy Raises $6.9 Million To Advance Preventive Screening …

6 days from now

Oct 2, 2019 · ST. LOUIS--(BUSINESS WIRE)-- Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, today …

biospace.com

$6
OFF

Geneoscopy Raises $6.9 Million To Advance Preventive Screening …

6 days from now

Oct 2, 2019 · The Company plans to use the proceeds from this financing to advance its colorectal cancer (CRC) screening test, which quantifies eukaryotic RNA isolated from …

biospace.com

$105
OFF

Geneoscopy Closes $105M In Financing To Advance Its …

6 days from now

LOUIS, Nov. 16, 2021 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the closing of a …

geneoscopy.com

$6
OFF

Geneoscopy Raises $6.9 Million To Advance Preventive Screening …

6 days from now

Oct 4, 2019 · ST. LOUIS--(BUSINESS WIRE)-- Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, today …

streetinsider.com

FAQs about Press Releases - Geneoscopy -Transforming Gastrointestinal Health Coupon?

What happened to geneoscopy?

ST. LOUIS, Nov. 16, 2021 /PRNewswire/ -- Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the closing of a Series B financing, raising a total of $105 million through a combination of debt and equity. ...

Does geneoscopy have a colorectal cancer screening test?

Geneoscopy has announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, ColoSense. ColoSense is a screening test for adults, 45 years of age or older, who are at average risk for developing colorectal cancer (CRC). ...

Does geneoscopy have a colosense test?

Geneoscopy says it will launch the ColoSense test in collaboration with Labcorp. Geneoscopy, a company focused on developing diagnostic tests for gastrointestinal health, announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, ColoSense. ...

Did geneoscopy get FDA approval for colosense?

Summary: Geneoscopy received FDA approval for ColoSense, a noninvasive colorectal cancer screening test using RNA biomarkers designed for adults at risk for colorectal cancer (CRC). Takeaways: ...

Does geneoscopy have a premarket approval?

Geneoscopy's test is not yet available for sale and is not yet approved by the U.S. Food and Drug Administration (FDA). A Premarket Approval submission to the FDA is planned for the first quarter of 2023. ...

Can geneoscopy help prevent colorectal cancer?

Despite being very preventable, colorectal cancer (CRC) is the second deadliest cancer in the US, causing over 50,000 deaths each year.¹ Geneoscopy’s noninvasive stool-based solution can reduce the barriers to screening and help address the gap in health equity. © 2024 Geneoscopy, Inc. ...